PPP is associated with increased cancer cell survival and proliferation (74, 77), implying the inhibition of phosphofructokinase (mainly PFK1) from glycolysis (78, 79), a direct competitor of glucose-6-phosphate dehydrogenase (G6PD), the limiting enzyme in PPP (75). This evidence concerns the gene G6PD and cancer.